QUO
- Product code
- QUO
- Device name
- Adjunctive Heart Failure Status Indicator
- Device class
- Class 2
- 21 CFR
- 21 CFR 870.2200
- Medical specialty
- Cardiovascular
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 4 (all years; only the last 3 years are listed here)
FDA classification definition
The adjunctive heart failure status indicator is a prescription device based on sensor technology or image data to provide information to an interpreting clinician in detecting heart failure. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K251293 | 2025-11-21 | Icardio.Ai | CardioVision | |
| K240013 | 2024-09-23 | Ultromics Limited | EchoGo Heart Failure (2.0) | |
| K223905 | 2023-10-06 | Avicena, LLC | Vivio® LVEDP System |
Official FDA classification page: QUO
Classification and pathway per current FDA publications. Data from openFDA (CC0).